<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction extraction-result-185 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extracted Data Details for extraction-result-185</h1>

        <div class="section">
            <h2>Extracted Data (Header)</h2>
            <div class="info-section">
                <p><strong>Extraction ID:</strong> extraction-result-185</p>
                <p><strong>Extraction Schema Used (ID):</strong> <a href="../schemas/extraction-schema-10.html">extraction-schema-10</a></p>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of autoimmune diseases in thymoma patients, including prevalence rates, proposed mechanisms, immunological findings, and clinical characteristics that explain the connection between thymomas and autoimmunity.</div>
                <p><strong>Paper ID:</strong> paper-63654559dc7b3b9611b65f73139f8fccaf98124e</p>
                <p><strong>Paper Title:</strong> <a href="https://www.semanticscholar.org/paper/63654559dc7b3b9611b65f73139f8fccaf98124e" target="_blank">Immune tolerance and the prevention of autoimmune diseases essentially depend on thymic tissue homeostasis</a></p>
                <p><strong>Paper Venue:</strong> Frontiers in Immunology</p>
                <p><strong>Paper TL;DR:</strong> Overall, this review underscores the integral role of thymic tissue homeostasis in the prevention of autoimmune diseases, discussing insights into potential therapeutic strategies and examining putative avenues for future research on developing thymic-based therapies in treating and preventing autoimmune conditions.</p>
                <p><strong>Paper Abstract:</strong> The intricate balance of immune reactions towards invading pathogens and immune tolerance towards self is pivotal in preventing autoimmune diseases, with the thymus playing a central role in establishing and maintaining this equilibrium. The induction of central immune tolerance in the thymus involves the elimination of self-reactive T cells, a mechanism essential for averting autoimmunity. Disruption of the thymic T cell selection mechanisms can lead to the development of autoimmune diseases. In the dynamic microenvironment of the thymus, T cell migration and interactions with thymic stromal cells are critical for the selection processes that ensure self-tolerance. Thymic epithelial cells are particularly significant in this context, presenting self-antigens and inducing the negative selection of autoreactive T cells. Further, the synergistic roles of thymic fibroblasts, B cells, and dendritic cells in antigen presentation, selection and the development of regulatory T cells are pivotal in maintaining immune responses tightly regulated. This review article collates these insights, offering a comprehensive examination of the multifaceted role of thymic tissue homeostasis in the establishment of immune tolerance and its implications in the prevention of autoimmune diseases. Additionally, the developmental pathways of the thymus are explored, highlighting how genetic aberrations can disrupt thymic architecture and function, leading to autoimmune conditions. The impact of infections on immune tolerance is another critical area, with pathogens potentially triggering autoimmunity by altering thymic homeostasis. Overall, this review underscores the integral role of thymic tissue homeostasis in the prevention of autoimmune diseases, discussing insights into potential therapeutic strategies and examining putative avenues for future research on developing thymic-based therapies in treating and preventing autoimmune conditions.</p>
                <p><strong>Cost:</strong> 0.019</p>
            </div>
        </div>

        <div class="section">
            <h2>Extracted Data (Details)</h2>
            <div class="extraction-instance-container" id="e185.0">
                <h3 class="extraction-instance">Extracted Data Instance 0 (e185.0)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of autoimmune diseases in thymoma patients, including prevalence rates, proposed mechanisms, immunological findings, and clinical characteristics that explain the connection between thymomas and autoimmunity.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>MG</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Myasthenia gravis</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Autoimmune disorder of the neuromuscular junction commonly associated with thymic pathology; in thymoma patients it is a frequent paraneoplastic autoimmune complication with characteristic thymic germinal centers and autoantibody production.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Immune tolerance and the prevention of autoimmune diseases essentially depend on thymic tissue homeostasis</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_name</strong></td>
                            <td>myasthenia gravis</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_prevalence</strong></td>
                            <td>In one analyzed cohort within the review: 34 out of 116 thymoma patients developed myasthenia gravis (≈29.3%); general statement: thymomas are commonly associated with myasthenia gravis (no global prevalence provided).</td>
                        </tr>
                        <tr>
                            <td><strong>thymoma_type</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Multiple, partly overlapping mechanisms described in the review: (1) neoplastic thymic epithelial cells in thymomas show reduced MHC class II and reduced AIRE expression leading to impaired presentation of tissue-restricted antigens and defective negative selection (escape of autoreactive T cells); (2) development of ectopic germinal centers and B cell maturation within the thymic tissue (thymic hyperplasia/GCs) enabling local autoantibody generation; (3) aberrant/ectopic neuromuscular antigen expression by medullary thymic epithelial cells (nmTECs) within MG-associated thymomas, promoting selection/activation of autoreactive B and T cells; (4) thymoma cells themselves may produce/induce autoantibodies or autoimmunizing signals (e.g., reported spontaneous production of anti-IFN-α and anti-IL-12 by thymoma cells in MG patients).</td>
                        </tr>
                        <tr>
                            <td><strong>immunological_findings</strong></td>
                            <td>Reported findings supporting mechanisms include: reduced MHCII and AIRE expression in thymoma epithelial cells; formation of germinal centers and B cell follicles with B cell maturation in MG-associated thymic tissue; aberrant neuromuscular gene expression in medullary TECs (ectopic expression of genes such as GABRA5, MAP2, NEFL, NEFM, SOX15 in KRT6+ GABRA5+ nmTEC subset); evidence of local production of autoantibodies by thymoma cells (anti-IFN-α and anti-IL-12 reported); disrupted thymic architecture with disturbed medulla and GC formation.</td>
                        </tr>
                        <tr>
                            <td><strong>autoantibodies_present</strong></td>
                            <td>Review cites spontaneous production by thymoma cells of anti-IFN-α and anti-IL-12 in MG patients; review also discusses Chrna1 (muscle AChR α-subunit) as the target of pathogenic autoantibodies in myasthenia gravis (implying anti-AChR antibodies are relevant to MG associated with thymic pathology).</td>
                        </tr>
                        <tr>
                            <td><strong>timing_relative_to_thymoma</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>effect_of_thymectomy</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>patient_characteristics</strong></td>
                            <td>MG-associated thymomas are characterized by thymic hyperplasia with germinal centers and enhanced B cell recruitment/maturation; chemokine/cytokine milieu changes (e.g., increased CXCL13, BAFF reported in thymic hyperplasia context) are implicated in recruiting B cells and promoting GC formation.</td>
                        </tr>
                        <tr>
                            <td><strong>thymic_structure_abnormalities</strong></td>
                            <td>Disturbed thymic architecture: reduced MHCII and reduced AIRE expression in thymoma epithelial cells; formation of lymphoid follicles/germinal centers within thymus; ectopic neuromuscular antigen-expressing mTEC populations (nmTECs); disturbed medulla and altered thymic microenvironment.</td>
                        </tr>
                        <tr>
                            <td><strong>t_cell_characteristics</strong></td>
                            <td>Inefficient central tolerance / defective negative selection leading to escape of autoreactive T cells (attributed to reduced AIRE and MHCII); altered thymic APC/T cell interactions that favor autoreactive T cell survival and possibly impaired generation of regulatory T cells (review links thymic dysfunction to defective T cell selection).</td>
                        </tr>
                        <tr>
                            <td><strong>comparison_with_without_autoimmunity</strong></td>
                            <td>True</td>
                        </tr>
                        <tr>
                            <td><strong>control_comparison</strong></td>
                            <td>The referenced cohort analysis (116 thymomas; 34 with MG) described MG-associated thymomas as having atypical immune microenvironments compared with non-MG thymomas: presence of germinal center formation, evidence of B cell maturation, and ectopic neuromuscular gene expression by medullary TECs (KRT6+ GABRA5+ nmTECs) in MG-associated cases; non-MG thymomas lacked these MG-specific features.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Immune tolerance and the prevention of autoimmune diseases essentially depend on thymic tissue homeostasis', 'publication_date_yy_mm': '2024-03'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e185.1">
                <h3 class="extraction-instance">Extracted Data Instance 1 (e185.1)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of autoimmune diseases in thymoma patients, including prevalence rates, proposed mechanisms, immunological findings, and clinical characteristics that explain the connection between thymomas and autoimmunity.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>PRCA</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Pure red cell aplasia</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>A hematologic autoimmune/paraneoplastic syndrome characterized by selective failure of erythroid precursors; noted as an autoimmune condition associated with thymomas.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Immune tolerance and the prevention of autoimmune diseases essentially depend on thymic tissue homeostasis</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_name</strong></td>
                            <td>pure red cell aplasia</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_prevalence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymoma_type</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Not specified in detail in this review; implied mechanisms are similar to other thymoma-associated autoimmunity (impaired central tolerance from altered thymic epithelial cell function, reduced AIRE/MHCII, and paracrine support for autoreactive lymphocyte (B/T) development).</td>
                        </tr>
                        <tr>
                            <td><strong>immunological_findings</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>autoantibodies_present</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>timing_relative_to_thymoma</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>effect_of_thymectomy</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>patient_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymic_structure_abnormalities</strong></td>
                            <td>General statement: thymomas exhibit abnormal thymic epithelial cell function (reduced MHCII and AIRE) and disturbed thymic architecture, which is implicated in paraneoplastic autoimmune manifestations including PRCA.</td>
                        </tr>
                        <tr>
                            <td><strong>t_cell_characteristics</strong></td>
                            <td>Not specifically described for PRCA in this review; overarching theme is escape of autoreactive T cells due to defective negative selection in thymoma-bearing thymus.</td>
                        </tr>
                        <tr>
                            <td><strong>comparison_with_without_autoimmunity</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>control_comparison</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Immune tolerance and the prevention of autoimmune diseases essentially depend on thymic tissue homeostasis', 'publication_date_yy_mm': '2024-03'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e185.2">
                <h3 class="extraction-instance">Extracted Data Instance 2 (e185.2)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of autoimmune diseases in thymoma patients, including prevalence rates, proposed mechanisms, immunological findings, and clinical characteristics that explain the connection between thymomas and autoimmunity.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>SLE</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Systemic lupus erythematosus</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Systemic autoimmune disease; the review notes associations between thymic abnormalities and lupus, and case reports linking thymoma and SLE (including after thymectomy).</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Immune tolerance and the prevention of autoimmune diseases essentially depend on thymic tissue homeostasis</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_name</strong></td>
                            <td>systemic lupus erythematosus</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_prevalence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymoma_type</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Not detailed for SLE specifically; the general model invoked is that thymic architectural disruption and defective central tolerance (reduced AIRE/MHCII, disorganized medulla, ectopic lymphoid/plasma cell infiltration) permit survival/activation of autoreactive lymphocytes that contribute to systemic autoimmunity.</td>
                        </tr>
                        <tr>
                            <td><strong>immunological_findings</strong></td>
                            <td>Patients with SLE show thymus atrophy with disorganized medulla, diminished cortex, enlarged perivascular spaces and lymphocytic follicles/plasma cells; thymoma case reports link thymoma/thymectomy with development or modulation of SLE, but mechanistic immunologic detail in this review is limited.</td>
                        </tr>
                        <tr>
                            <td><strong>autoantibodies_present</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>timing_relative_to_thymoma</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>effect_of_thymectomy</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>patient_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymic_structure_abnormalities</strong></td>
                            <td>Thymic atrophy and disorganized medulla, diminished cortex, enlarged perivascular spaces with lymphocytic follicles and plasma cells are described in SLE patients; thymoma-associated thymic structural abnormalities include reduced AIRE/MHCII and disrupted architecture.</td>
                        </tr>
                        <tr>
                            <td><strong>t_cell_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_with_without_autoimmunity</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>control_comparison</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Immune tolerance and the prevention of autoimmune diseases essentially depend on thymic tissue homeostasis', 'publication_date_yy_mm': '2024-03'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e185.3">
                <h3 class="extraction-instance">Extracted Data Instance 3 (e185.3)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of autoimmune diseases in thymoma patients, including prevalence rates, proposed mechanisms, immunological findings, and clinical characteristics that explain the connection between thymomas and autoimmunity.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Graves</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Graves' disease</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Autoimmune thyroid disease; the review links thymic lymphocytic hyperplasia to Graves' disease and describes thymic enlargement/hyperplasia as associated with some autoimmune conditions.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Immune tolerance and the prevention of autoimmune diseases essentially depend on thymic tissue homeostasis</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_name</strong></td>
                            <td>Graves' disease</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_prevalence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymoma_type</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Not explicitly detailed for Graves' disease in the review; association is via thymic lymphocytic hyperplasia (increased lymphoid follicles/germinal centers) that can foster B cell activation and autoantibody generation against thyroid antigens.</td>
                        </tr>
                        <tr>
                            <td><strong>immunological_findings</strong></td>
                            <td>Thymic lymphocytic hyperplasia characterized by increased lymphoid follicles with germinal centers is associated with Graves' disease; chemokine/cytokine milieu changes (e.g., CXCL13, BAFF) are implicated in B cell recruitment and activation in thymic hyperplasia contexts.</td>
                        </tr>
                        <tr>
                            <td><strong>autoantibodies_present</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>timing_relative_to_thymoma</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>effect_of_thymectomy</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>patient_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymic_structure_abnormalities</strong></td>
                            <td>Thymic lymphocytic hyperplasia with germinal center formation and disturbed thymic architecture.</td>
                        </tr>
                        <tr>
                            <td><strong>t_cell_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_with_without_autoimmunity</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>control_comparison</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Immune tolerance and the prevention of autoimmune diseases essentially depend on thymic tissue homeostasis', 'publication_date_yy_mm': '2024-03'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <div class="section">
            <h2>Potentially Relevant New Papers (mentioned by this paper)</h2>
            <ol>
                <li>Thymoma associated with autoimmune diseases: 85 cases and literature review <em>(Rating: 2)</em></li>
                <li>Autoimmune disorders and paraneoplastic syndromes in thymoma <em>(Rating: 2)</em></li>
                <li>A tale of autoimmunity: thymoma, thymectomy, and systemic lupus erythematosus <em>(Rating: 2)</em></li>
                <li>Myasthenia gravis-specific aberrant neuromuscular gene expression by medullary thymic epithelial cells in thymoma <em>(Rating: 2)</em></li>
                <li>Spontaneous production of anti-IFN-alpha and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor <em>(Rating: 2)</em></li>
                <li>Deficiency of the autoimmune regulator aire in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (Aps-1) <em>(Rating: 2)</em></li>
                <li>Autoimmune disease in patients with advanced thymic epithelial tumors <em>(Rating: 2)</em></li>
            </ol>
        </div>

        </div>

    </div>
</body>
</html>